453 related articles for article (PubMed ID: 33516778)
21. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
Farmer RE; Ford D; Mathur R; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K
Int J Epidemiol; 2019 Apr; 48(2):527-537. PubMed ID: 30753459
[TBL] [Abstract][Full Text] [Related]
22. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
23. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
[TBL] [Abstract][Full Text] [Related]
24. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
25. Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer.
Lawrence WR; Hosler AS; Gates Kuliszewski M; Leinung MC; Zhang X; Schymura MJ; Boscoe FP
Cancer Epidemiol; 2020 Jun; 66():101710. PubMed ID: 32247208
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis.
Cheng C; Lin CH; Tsai YW; Tsai CJ; Chou PH; Lan TH
J Gerontol A Biol Sci Med Sci; 2014 Oct; 69(10):1299-305. PubMed ID: 24899525
[TBL] [Abstract][Full Text] [Related]
27. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
28. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
[TBL] [Abstract][Full Text] [Related]
29. Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts.
Hu Y; Zhang X; Ma Y; Yuan C; Wang M; Wu K; Tabung FK; Tobias D; Hu FB; Giovannucci E; Song M
J Natl Cancer Inst; 2021 Apr; 113(4):381-389. PubMed ID: 33225344
[TBL] [Abstract][Full Text] [Related]
30. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
31. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
32. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
34. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
Feng JL; Qin X
Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
[TBL] [Abstract][Full Text] [Related]
35. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
36. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
37. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.
Gong Z; Aragaki AK; Chlebowski RT; Manson JE; Rohan TE; Chen C; Vitolins MZ; Tinker LF; LeBlanc ES; Kuller LH; Hou L; LaMonte MJ; Luo J; Wactawski-Wende J
Int J Cancer; 2016 Apr; 138(8):1915-27. PubMed ID: 26616262
[TBL] [Abstract][Full Text] [Related]
38. Metformin use and lung cancer risk in patients with diabetes.
Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes.
Chikermane SG; Sharma M; Abughosh SM; Aparasu RR; Trivedi MV; Johnson ML
Breast Cancer Res Treat; 2022 Oct; 195(3):421-430. PubMed ID: 35969285
[TBL] [Abstract][Full Text] [Related]
40. Making sense of associations between type 2 diabetes, metformin, and breast cancer risk.
Park YM; Sandler DP
Br J Cancer; 2021 Sep; 125(7):909-910. PubMed ID: 33911196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
